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Background: The number of individual patient data meta-analyses published is very low especially in surgical
domains. Our aim was to assess the feasibility of individual patient data (IPD) meta-analyses in orthopaedic surgery
by determining whether trialists agree to send IPD for eligible trials.
Methods: We performed a literature search to identify relevant research questions in orthopaedic surgery. For
each question, we developed a protocol synopsis for an IPD meta-analysis and identified all related randomized
controlled trials (RCTs) with results published since 2000. Corresponding authors of these RCTs were sent personalized
emails that presented a project for an IPD meta-analysis corresponding to one of the research questions, with a link to
the protocol synopsis, and asking for IPD from their RCT. We guaranteed patient confidentiality and secure data storage,
and offered co-authorship and coverage of costs related to extraction.
Results: We identified 38 research questions and 273 RCTs related to these questions. We could contact 217 of
the 273 corresponding authors (79 %; 56 had unavailable or non-functional email addresses) and received 68/273
responses (25 %): 21 authors refused to share IPD, 10 stated that our request was under consideration and 37
agreed to send IPD. Four corresponding authors required authorship and three others asked for financial support
to send the IPD. Overall, we could obtain IPD for 5,110 of 33,602 eligible patients (15 %). Among the 38 research
questions, only one IPD meta-analysis could be potentially initiated because we could receive IPD for more than
50 % of participants.
Conclusion: The present study illustrates the difficulties in initiating IPD meta-analyses in orthopaedic surgery.
Significant efforts must be made to improve data sharing.
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Individual patient data (IPD) meta-analyses (MAs) are
generally considered to provide the highest level of evi-
dence [1]. IPD MAs have theoretical advantages over
MAs of aggregated data because the use of original
source material allows for standardizing analyses across
studies and trial results are obtained directly, independ-
ent of the quality of reporting [1–3]. Nevertheless, the
number of IPD MAs published is very low, with a mean
of 49 IPD MAs published each year between 2005 and
2009 [1] as compared with thousands of MAs of* Correspondence: agnes.dechartres@htd.aphp.fr
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creativecommons.org/publicdomain/zero/1.0/aggregated data. The number of IPD MAs is particularly
low in surgical domains. In a recent systematic review of
IPD MAs, 22 of the 583 IPD MAs published between
2005 and 2012 assessed surgical interventions [4].
The main barrier to performing an IPD MA is the lack
of data sharing by researchers. Many researchers are re-
luctant to share IPD because of patient protection, own-
ership [5], or the cost [1, 6] to ensure confidentiality and
anonymity of patients and archiving the data [1, 7].
Moreover, additional pitfalls, such as the availability of
data [8] with practical difficulties related to data sharing
many years after the completion of a trial, potentiate the
risk of an incomplete data sharing process. There is an
evolution in ideas and thinking about data sharing among
researchers [9–16], funders [17–19], the Cochrane col-
laboration [20] and journals [21–25]. However, to ouricle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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lished by orthopaedic journals or institutions. Thus, data
sharing in orthopaedic surgery relies mainly on cooper-
ation from the clinical trialists who generate and maintain
these data.
In the present study, we aimed to assess the feasibility
of performing IPD MAs in orthopaedic surgery, testing
whether trialists agree to share IPD for IPD MAs. We
also assessed the conditions that allow for such data
sharing.
Methods
In a first step, we identified orthopaedic clinical research
questions that could be evaluated with IPD MAs. Then,
using personalized emails, we systematically contacted
corresponding authors of randomized controlled trials
(RCTs) related to those clinical questions and asked
them whether they would agree to share the IPD from
their trials for an MA.
Identification of clinical research questions in orthopaedic
surgery
To identify relevant clinical research questions in ortho-
paedic surgery that could justify an IPD MA, we relied
on questions assessed in recently published systematic
reviews with MAs of aggregated data.
Search of systematic reviews with MAs of aggregated data
assessing orthopaedic surgical procedures
On 6 April 2014, we searched MEDLINE via PubMed for
systematic reviews published between 1 January 2013 and
31 December 2013, using the search equation reported in
Additional file 1. This search equation combined MESH
terms related to: orthopaedics and free-text words corre-
sponding to the main orthopaedic surgical procedures;
publication type and free-text words corresponding to-
systematic reviews and MAs; and a modified version of
the Cochrane Highly Sensitive Search Strategy to identify
RCTs. In addition, we performed a search of the Cochrane
Database of Systematic Reviews (Orthopaedics and
Trauma and Rheumatology) to identify Cochrane system-
atic reviews assessing an orthopaedic surgical procedure
and published in 2013. The search results were pooled
and duplicate records were removed.
Selection of systematic reviews
The title, abstract and full text, when necessary, of all
identified references were screened by two authors (BV
and PB). We included systematic reviews written in Eng-
lish or French and published in 2013 that assessed an
orthopaedic surgical procedure, with no restriction on
comparator (usual care, placebo, conservative interven-
tion, pharmacological treatment or other surgical im-
plant or procedure), and including an MA of aggregateddata based on two or more RCTs. Systematic reviews
and MAs that were withdrawn were excluded, as were
those for which the full text was not available.
Extraction of clinical research questions from the systematic
reviews
Two reviewers (BV and PB) independently extracted all
elements of the clinical research question assessed from
the full text of the systematic reviews by using the Popu-
lation, Intervention tested, Comparator and primary
Outcomes (PICO) acronym [26]. Then, all clinical ques-
tions were classified by anatomical region (e.g., shoulder)
and surgical procedure tested (e.g., arthroplasty) to iden-
tify any potentially redundant research questions.
Development of protocol synopsis of IPD MA for each
clinical research question
For each clinical research question, we developed a
standardized protocol synopsis for an IPD MA, with
the background and objectives sections derived from
the corresponding systematic review with MA of aggre-
gated data and the methods section based on the
Cochrane Handbook for Systematic Reviews of Interven-
tions [27]. An example of a protocol synopsis is pre-
sented in Additional file 2.
Identification of RCTs relevant to the clinical research
questions
We identified all RCTs included in the systematic re-
views with MA of aggregated data for the clinical re-
search questions. All RCTs were selected provided they
were written in English or French and results were pub-
lished since 2000, because for trials with results published
before 2000, we anticipated difficulties in contacting cor-
responding authors and obtaining IPD from these trials.
Non-randomized studies and quasi-RCTs were excluded,
as were RCTs not indexed in MEDLINE. If corresponding
authors were involved in several RCTs corresponding to
different clinical research questions, we contacted them
for only one clinical question chosen at random. Only
the RCTs corresponding to this clinical question were
selected.
Extraction of characteristics of the selected RCTs
Using a pre-tested standardized form, we extracted the
following characteristics from the full text and online
Additional files, as well as journal websites:
 Corresponding author: name and email address of
the corresponding author. When the email address
was not available in the article or not functional, the
name was entered in PubMed to search for another
study published by the author for which the email
address was reported. We also screened the website
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 Characteristics of the trial: publication date, whether
the trial was a single-centre or multicentre trial,
location of the study (Africa, Asia, Australia and
New Zealand, Europe, North America, South
America) and funding source (public, private, both
public and private, not reported). The geographic
location of the corresponding author’s affiliated
institution was used to define the location of the
study when the study location was not reported or
when the RCT was an international multicentre
study. We also extracted the number of patients
randomized in each RCT.
 Characteristics of the journal in which the RCT was
published: name of the journal, whether it was
specialized or general and its impact factor. We
classified journals according to whether they were
in the 10 highest impact factors for a medical
condition according to the Journal Citation Reports.
We also recorded whether the journal had a data
sharing policy and, if so, whether data sharing was a
mandatory condition to publish.
Contacting the corresponding authors of identified RCTs
Corresponding authors of each RCT were contacted by
personalized email to participate in a specific IPD MA
project and to provide IPD from their RCT. The email
stated that the French Cochrane Centre aimed to initiate
collaboration among trialists to perform IPD MAs on
important orthopaedic topics and that the first project
had as an objective the clinical research question for
which the RCT was eligible. We guaranteed protection
of patient data and secure storage of datasets. We also
systematically asked whether the corresponding author
or another colleague wanted to be a co-author of the
published IPD MA and whether we should cover costs
related to data extraction. The emails were personalized
for each trialist and clinical research question, with in-
clusion of the name of the corresponding author, title,
year of publication and journal in which the author’s
trial was published, as well as the objective of the IPD
MA and a link to the protocol synopsis of the IPD MA
corresponding to the research question assessed. The
subject of the email was ‘Your article ‘Trial title’, pub-
lished in ‘Journal’ on ‘Year of publication”. Emails were
sent using a dedicated Cochrane address and were
signed by an academic orthopaedic surgeon on behalf of
the French Cochrane Centre, the French Equator Centre
and the Inserm Research Centre U1153. An example of
the email sent is available in Additional file 3. Two simi-
lar reminders were sent to the authors 15 and 30 days
after the first email if we did not receive a response to
the initial request.It has to be noted that our hypothesis was that the rate
of positive answers would be low but we expected to be
able to perform several IPD meta-analyses as part of a PhD
program for the clinical questions for which we would have
received a sufficient number of positive answers.
Statistical analyses
Characteristics of systematic reviews and RCTs were de-
scribed along with the number and percentage for cat-
egorical variables. We compared characteristics of trials
and journals for trials for which we had a positive re-
sponse and a negative or no response to our request for
data sharing by two-sided chi-square or Fisher’s exact
test, as appropriate, with a type I error level of 0.05. We
excluded from this comparison authors who responded
that our request was under consideration. Data were an-
alyzed by using R version 2.13.1 [28].
Results
Identification of clinical research questions in orthopaedic
surgery
Additional file 4 describes the flow of the selection of sys-
tematic reviews. Briefly, we screened 418 records and se-
lected 63 systematic reviews with MA of aggregated data
corresponding to 38 different clinical research questions
described in Table 1. The main characteristics of the 63
systematic reviews are presented in Additional file 5.
Identification of RCTs corresponding to the clinical
research questions
From the full text of these 63 systematic reviews, we identi-
fied 525 trials and selected 284 eligible trials 11 were
further excluded because the corresponding authors
were involved in several RCTs assessing different
research questions, so our study was based on 273
RCTs (Fig. 1).
Characteristics of the selected RCTs
The main characteristics of the RCTs are summarized in
Table 2. Briefly, 183 RCTs (67 %) were single-centre tri-
als; 60 (22 %) were multicentre trials, with unknown sta-
tus for 30 trials (11 %). Most of the trials took place in
Europe, North America and Asia (39 %, 29 % and 29 %,
respectively). The funding source was reported for 53 %
of RCTs and was public for 35 %. Forty-two percent of
RCTs were published between 2010 and 2013. Most of
the RCTs (95 %) were published in specialized journals.
Only 32 (12 %) were published in journals that had a
clearly described data sharing policy.
Data sharing request
The email address of the corresponding author was
available and functional for 217 of the 273 RCTs (79 %).
We received 68 responses (Fig. 2). In total, 37 authors,
Table 1 Description of the 38 identified clinical research questions in orthopaedics
Anatomic area Pathology Intervention Comparator Primary outcomes
Shoulder Rotator cuff tears Arthroscopic double-row repair Arthroscopic single-row repair Function
Midshaft clavicular fractures Surgical treatment Non-operative treatment Function
Proximal humeral fractures in
older patients
Surgical treatment Non-operative treatment Function
Osteoarthritis Total shoulder arthroplasty Shoulder hemiarthroplasty Function
Arm Humeral shaft fracture Intramedullary nail Internal fixation with plate Function
Elbow Supracondylar fractures in
children
Lateral pin fixation Crossed pin fixation Function, iatrogenic ulnar nerve
injury
Wrist Distal radial fractures Anterior ORIF External fixation Function, radiographic
consolidation
Distal radial fractures Anterior ORIF Posterior ORIF Function, radiographic
consolidation
Hip Osteoarthritis Minimally invasive approach Standard approach Function, revision rate
Osteoarthritis No wound drainage after THA Wound drainage after THA Function, wound infection,
wound haematoma
Osteoarthritis Navigated THA Conventional arthroplasty Function, revision rate, dislocation
Intracapsular fractures Uncemented hemiarthroplasty Cemented hemiarthroplasty Mortality, function, pain at 1 year,
revision rate
Osteoarthritis Uncemented THA Cemented THA Function, revision rate
Hip and knee Osteoarthritis Antibiotic impregnated cement Non-antibiotic-impregnated
cement
Postoperative infection rate
Knee Osteoarthritis TKA, minimally invasive
approach
Standard approach for TKA Function
Osteoarthritis Mobile-bearing TKA Fixed-bearing TKA Function, reoperation rate
Osteoarthritis TKA without tourniquet TKA under tourniquet Function, total blood loss
Osteoarthritis Drainage clamping after TKA TKA conventional drainage Hb loss, transfusion, function
Osteoarthritis No patellar resurfacing in TKA Patellar resurfacing in TKA Function, reoperation rate,
anterior knee pain
Osteoarthritis PCL-retaining TKA Posterior-stabilized TKA Function, reoperation rate
Osteoarthritis TKA electrocautery of patella No electrocautery of patella Function, reoperation rate,
anterior knee pain
Osteoarthritis Gender-specific TKA Unisex TKA Function, reoperation rate, pain,
Osteoarthritis Unicompartmental knee
arthroplasty
Tibial osteotomy Function, reoperation rate





ACL tears Early ACL reconstruction Delayed ACL reconstruction Function, reoperation rate
ACL tears Allograft ACL reconstruction Autograft ACL reconstruction Function, reoperation rate





Leg Distal tibial shaft fractures Intramedullary nailing Internal fixation with plate Function, nonunion and
malunion rate




Ankle Acute Achilles tendon rupture Early weight bearing Delayed weight bearing Function, rerupture rate






Foot Calcaneal fractures Surgical treatment Non-operative treatment Function, chronic pain
Spine Cervical disc disease Cervical disc arthroplasty Cervical interbody fusion Function, pain
Osteoporotic vertebral fractures Percutaneous vertebroplasty Conservative treatment Function, pain, quality of life
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Table 1 Description of the 38 identified clinical research questions in orthopaedics (Continued)
Osteoporotic vertebral fractures Bilateral pedicular kyphoplasty Unilateral pedicular
kyphoplasty
Function, pain, quality of life
Lumbar disc disease Lumbar disc arthroplasty Lumbar interbody fusion Function, pain
Thoracolumbar burst fractures Fracture fixation associated to
fusion
Fracture fixation alone Function, pain, quality of life
Thoracolumbar burst fractures Surgical treatment Conservative treatment Function, pain, quality of life
ACL: Anterior cruciate ligament; Hb: Haemoglobin; ORIF: Open reduction and internal fixation; PCL: Posterior cruciate ligament; THA: Total hip arthroplasty; TKA:
Total knee arthroplasty
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30 without any conditions, four requiring co-authorship
and three asking for financial support to send the IPD.
Ten additional authors said that our request was under
evaluation by the research team or sponsor and 21 au-
thors refused to participate and to send IPD. Authors
who refused to send IPD did so because of no access to
the data (n = 8), ethical concerns (n = 5), lack of time
(n = 5) and no reason (n = 3).
Feasibility of IPD MAs in orthopaedic surgery
Overall, we obtained agreement to receive IPD for 5,110
of 33,602 eligible patients (15 %). We obtained agree-
ment to receive IPD for more than 50 % of participants405 trials after removal 
of duplicates












525 trials identified after 
screening the SRs
120 d
Fig. 1 Flow chart of the selection of randomized controlled trials (RCTs) cofor only one of the 38 clinical research questions. This
question concerned comparing external fixation and in-
ternal anterior fixation for distal radial fracture with 399
participants (five studies) among 712 eligible (nine stud-
ies) (56 %) (Fig. 3).
Comparison of characteristics of RCTs with a positive
response and negative or no response to the request for
data sharing
We did not identify any factor significantly associated
with a positive response to our request for data sharing
(Table 3). We received a positive response for 19/176
(11 %) single-centre trials, 11/57 (19 %) multicentre tri-
als (P = 0.07), 20/117 (17 %) trials published in the topials excluded
9 Not indexed in PubMed
2 Not published
2 Not registered on website journal
CTs randomly excluded (same 
sponding authors for RCTs assessing 
rent research questions)
ials excluded
3 Published before 2000
8 Full text not available on
Pubmed, not in English or French
7 Studies categorised as not RCTs
after full text screening
uplicate articles
rresponding to the 38 clinical research questions
Table 2 General characteristics of the randomized controlled
trials (RCTs) related to the clinical research questions (n = 273)




Single-centre 183 (67 %)
Multicentre 60 (22 %)
Not reported 30 (11 %)
Location
Europe 106 (39 %)
North America 80 (29 %)
Asia 78 (29 %)
Australia and New Zealand 9 (3 %)
Funding
Public 96 (35 %)
Private 49 (18 %)
Not reported 128 (47 %)
Year of publication
2000–2004 46 (17 %)
2005–2009 112 (41 %)
2010–2013 115 (42 %)
Journal of publication characteristics
Type of journal
Specialized 260 (95 %)
Generalist 13 (5 %)
Top 10 impact factor of each specialty
No 156 (57 %)
Yes 117 (43 %)
Journal data sharing policies
No policy 241 (88 %)
Incentive measures 24 (9 %)
Mandatory 8 (3 %)
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(12 %) trials not published in the top 10 journals (P =
0.21). We received a positive response for 2/30 (7 %) tri-
als published in journals with data sharing policies and
35/233 (15 %) trials published in journals without data
sharing policies (P = 0.27).
Discussion
In this study, we requested IPD from corresponding au-
thors for 273 RCTs in order to perform 38 IPD MAs
covering different orthopaedic clinical research ques-
tions. Our results highlight the difficulty in performing
IPD MAs. We could contact only 79 % of the identified
corresponding authors despite additional searches on
PubMed and the website for the author’s affiliation. Theresponse rate was only 25 % (68/273 authors), with only
14 % (37/273) agreeing to participate in the IPD MA
project. Because of this low rate of participation, only
one IPD MA among the 38 planned could be potentially
initiated.
Strengths and weaknesses
To the best of our knowledge, this study was the first to
assess the feasibility of performing a large number of IPD
MAs in real conditions. We had a pragmatic approach in
adopting the point of view of researchers willing to initiate
IPD MAs. Emails were personalized to each trialist and to
each research question, with the protocol synopsis corre-
sponding to the specific clinical question provided. We fo-
cused on orthopaedics because the number of clinical
trials performed in this field is low [29–31] as compared
with other specialties, so cooperation of trialists and data
sharing are crucial to provide high-level evidence regard-
ing the efficacy of interventions.
Some potential limitations should be discussed. We
attempted to contact corresponding authors by email
only. The rate of response could have been higher if we
had contacted authors by telephone or postal mail. Also,
it could have been higher with the collaboration of
learned societies. We were able to contact only 79 % of
investigators because of invalid email addresses, which
can be explained by their moving to another institution.
Author identification initiatives and online research pro-
files such as ResearchGate could help identify contact
information of investigators [32]. The positive responses
we received were an agreement to share IPD, but with
no guarantee to finally obtain the IPD, so we may have
overestimated the real number of datasets available for
our IPD MA projects. Finally, Hannink et al. [4] identi-
fied an IPD MA published in 2011 assessing a question
close to one of our 38 questions, which may explain the
lack of positive response for this question [33].
Comparison with other studies
Some authors previously surveyed trialists’ opinions on
data sharing, with most respondents in favour of sharing
IPD [34, 35]. The difference from our results may be due
to the fact that surveyed trialists were corresponding au-
thors of trials recently published in general journals with
the highest impact factor [34], some of these journals
having adopted strong data sharing policies [22]. Also, our
pragmatic approach may explain the difference. There is
probably a gap between favouring data sharing and
actually sending the IPD. There are some rare examples
concerning a particular case reporting the difficulties en-
countered in obtaining IPD [36–39] including for per-
forming IPD MAs [38, 39]. Jaspers et al. could not initiate
an IPD MA on proton magnetic resonance spectroscopy
in neonatal hypoxic-ischemic encephalopathy, receiving








37 positive response (14%)
5110 patients /33602 (15%)
10 sharing under 
consideration (4%)
1573 patients/33602 (5%)
21 negative response (8%)
5292 patients/33602 (16%)
Fig. 2 Flow chart of data sharing request process
Fig. 3 Distribution of answers to request for data sharing by clinical questions. ACL: Anterior cruciate ligament; THA: Total hip arthroplasty; TKA:
Total knee arthroplasty
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Table 3 Characteristics of RCTs with a positive response and negative or no response to the request for data sharing
Characteristics Data sharing requesta (n = 263) P value
n (%)
Positive response Negative or no response
37 (14%) 226 (86%)
RCT characteristics
Study design 0.07
Single-centre (n = 176) 19 (11%) 157 (89%)
Multicentre (n = 57) 11 (19%) 46 (81%)
Not reported (n = 30) 7 (23%) 23 (77%)
Location 0.11
Europe (n = 105) 20 (19%) 85 (81%)
North America (n = 71) 9 (13%) 62 (87%)
Asia (n = 78) 6 (8%) 72 (92%)
Australia and New Zealand (n = 9) 2 (22%) 7 (78%)
Funding 0.19
Public (n = 91) 8 (9%) 83 (91%)
Privateb (n = 45) 7 (16%) 38 (84%)
No response (n = 127) 22 (17%) 105 (83%)
Year of publication 0.57
2000–2004 (n = 44) 4 (9%) 40 (91%)
2005–2009 (n = 109) 16 (15%) 93 (85%)
2010–2013 (n = 110) 17 (15%) 93 (85%)
Journal of publication characteristics
Journal of publication 0.68
Specialized (n = 251) 35 (14%) 216 (86%)
Generalist (n = 12) 2 (17%) 10 (83%)
Journal data sharing policies 0.27
Yes (support or mandatory) (n = 30) 2 (7%) 28 (93%)
No (n = 233) 35 (15%) 198 (85%)
Top 10 impact factor in each specialty 0.21
Yes (n = 117) 20 (17%) 97 (83%)
No (n = 146) 17 (12%) 129 (88%)
aTen trials excluded because our request was being evaluated by the research team or sponsor at the time of statistical analysis; btotal number (n = ) used for
calculating the percentage
Villain et al. BMC Medicine  (2015) 13:131 Page 8 of 10five favourable responses among 18 contacts [38]. The
Cochrane Epilepsy Group recently reported their difficul-
ties in performing review updates, with IPD obtained for
only 299 participants (four studies) among the 7,811 eli-
gible (37 studies identified) [39].
Possible explanations and implications
The arguments given by corresponding authors for re-
fusing to send IPD agree with the barriers to data shar-
ing described in the literature: concerns about
protecting patient confidentiality and anonymity [1, 7,
40], lack of time and costs [1], and unusable datasets [1].Practical solutions and guidelines to circumvent those
obstacles have been proposed [12, 14, 40, 41], but signifi-
cant efforts must be made to raise the awareness of the
surgical community about the benefits of data sharing.
Data sharing is a necessary condition to perform IPD
meta-analyses, recognized as providing the highest level
of evidence. This type of study is of great interest in do-
mains for which randomized controlled trials are diffi-
cult to perform, such as in surgery to increase precision
and power, to improve external validity and to perform
subgroup analyses. Nevertheless, to be relevant, an IPD
meta-analysis should be based on all relevant evidence
Villain et al. BMC Medicine  (2015) 13:131 Page 9 of 10and not on a subset (potentially biased) of eligible trials
[1, 2, 8]. In this study, we focused on orthopaedics but it
is likely that other surgical domains may be concerned.
In a recent methodological review of 583 identified IPD
meta-analyses, only 22 (4 %) concerned a surgical inter-
vention [4].
Things are moving with a push toward more data
sharing among researchers and some journals [21, 22]
that require authors to make the relevant anonymized
patient-level data available on reasonable request and to
provide a data sharing statement in each article. Major
academic funders as well as some pharmaceutical com-
panies are also adopting policies to support this sharing
of data. This movement should also spread to surgical
domains. Specialized journals, learned societies, funders
as well as research leaders have a major role to play to
help improve data sharing in surgical domains. Never-
theless, there are practical issues as sharing data 10 years
after the completion of a trial may be difficult related to
availability and format of data, and because there is no
patient consent. The responsibility for cleaning, storing
and sharing databases is so far supported by individual re-
searchers. As outlined in an article published in Current
Biology, in the long term, research data cannot be reliably
preserved by individual researchers [32]. Data cleaning,
storage and export in a suitable format represent an im-
portant burden for researchers with no specific funding
dedicated to this process. Also, investigators may move to
another institution, which presents difficulties in contact-
ing them. Therefore, institutions and funders should have
the responsibility for data storage. A major change could
be obtained by the establishment of central repositories,
domain by domain, with close collaboration between re-
searchers, funders and learned societies to securely de-
posit IPD in a standardized format promptly after trial
completion. The development of such repositories is on-
going in some domains, such as rheumatology with the
Osteoarthritis Trial Bank [42]. Patient consent to deposit
anonymous data on a repository and standardization of
data could be planned along with the clinical trial to facili-
tate the process. Finally, as recently outlined by Ioannidis,
the current system does not reward enough data sharing
[43]. Additional value should be given to researchers who
agree to share their data.
Conclusions
The present study illustrates the difficulties in initiating
IPD MAs in orthopaedic surgery. Even under the most
favourable conditions (recent trials, request by the French
Cochrane Centre, co-authorship, coverage of costs related
to data extraction), the number of trials for which IPD
could be obtained was low. Significant efforts must be
made by the different players in medical research to im-
prove data sharing in the surgical community.Key messages
This study outlines the practical difficulties in perform-
ing IPD MAs in orthopaedics.
 We obtained a response rate of 25 % to our request
for IPD, with only 14 % of authors agreeing to send
IPD.
 Overall, we obtained agreement for IPD sharing
concerning 5,110 of 33,602 eligible patients.
 We obtained agreement to receive IPD for more
than half of participants for only one of the 38 IPD
MA projects that could have been initiated.
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